Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes

Carcinogenesis

Volumn 26, Issue 2, 2005, Pages 343-351

  Piton, Amélie ^a   Le Ferrec, Eric ^a   Langouët, Sophie ^a   Rauch, Claudine ^a   Petit, Elise ^a   Le Goff, Frédérick ^a   Guillouzo, André ^a   Morel, Fabrice ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MESSENGER RNA; OLTIPRAZ; XENOBIOTIC AGENT;

ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; UNINDEXED SEQUENCE;

ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; PYRAZINES; RNA, MESSENGER;

EID: 13844280923     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh316     Document Type: Article

References (34)

1. Langouet,S., Morel,F. and Guillouzo,A. (2004) Effect of oltipraz on phase I and phase II xenobiotic metabolizing enzymes. In Bao,Y. and Fenwick,R. (eds) Phytochemicals in Health and Disease. Marcel Dekker, New York, NY, pp. 311-329.
2. Kwak,M.K., Egner,P.A., Dolan,P.M., Ramos-Gomez,M., Groopman,J.D., Itoh,K., Yamamoto,M. and Kensler,T.W. (2001) Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480/481, 305-315.
3. Langouet,S., Furge,L.L., Kerriguy,N., Nakaimura,K., Guillouzo,A. and Guengerich,F.P. (2000) Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives and sulforaphane. Chem. Res. Toxicol., 13, 245-252.
4. Morel,F., Fardel,O., Meyer,D.J. et al. (1993) Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene and dithiolethiones. Cancer Res., 53, 231-234.
5. Maheo,K., Morel,F., Antras-Ferry,J., Langouet,S., Desmots,F., Corcos,L. and Guillouzo,A. (1998) Endotoxin suppresses the oltipraz-mediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat. Hepatology, 28, 1655-1662.
6. Primiano,T., Li,Y., Kensler,T.W., Trush,M.A. and Sutter,T.R. (1998) Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis, 19, 999-1005.
7. Payen,L., Sparfel,L., Courtois,A., Vernhet,L., Guillouzo,A. and Fardel,O. (2002) The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol. Toxicol., 18, 221-233.
8. Langouet,S., Maheo,K., Berthou,F., Morel,F., Lagadic-Gossmann,D., Glaise,D., Coles,B., Ketterer,B. and Guillouzo,A. (1997) Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP213 in rat liver and rat hepatocytes in culture. Carcinogenesis, 18, 1343-1349.
9. Antras-Ferry,J., Maheo,K., Chevanne,M., Dubos,M.P., Morel,F., Guillouzo,A., Cillard,P. and Cillard,J. (1997) Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes. Carcinogenesis, 18, 2113-2117.
10. Kwak,M.K., Wakabayashi,N., Itoh,K., Motohashi,H., Yamamoto,M. and Kensler,T.W. (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem., 278, 8135-8145.
11. Kensler,T.W., Egner,P.A., Wang,J.B. et al. (2002) Strategies for chemoprevention of liver cancer. Eur. J. Cancer. Prev. 11 (suppl. 2), S58-S64.
12. Zhang,B.C., Zhu,Y.R., Wang,J.B. et al. (1997) Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China. J. Cell. Biochem., 28-29 (suppl.), 166-173.
13. Wang,J.S., Shen,X., He,X. et al. (1999) Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl Cancer Inst. 91, 347-354.
14. Gupta,E., Olopade,O.I., Ratain,M.J., Mick,R., Baker,T.M., Berezin,F.K., Benson,A.B.,III and Dolan,M.E. (1995) Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent. Clin. Cancer Res., 1, 1133-1138.
15. Yao,K.S. and O'Dwyer,P.J. (2003) Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention. Biochem. Pharmacol., 66, 15-23.
16. Primiano,T., Kensler,T.W., Kuppusamy,P., Zweier,J.L. and Sutter,T.R. (1996) Induction of hepatic heme oxygenase-1 and, ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis, 17, 2291-2296.
17. Cherrington,N.J., Slitt,A.L., Maher,J.M., Zhang,X.X., Zhang,J., Huang,W., Wan,Y.J., Moore,D.D. and Klaassen,C.D. (2003) Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab. Dispos. 31, 1315-1319.
18. Le Ferrec,E., Lagadic-Gossmann,D., Rauch,C., Bardiau,C., Maheo,K., Massiere,F., Le Vee,M., Guillouzo,A. and Morel,F. (2002) Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent. J. Biol. Chem., 277, 24780-24787.
19. Langouet,S., Coles,B., Morel,F., Becquemont,L., Beaune,P., Guengerich,F.P., Ketterer,B. and Guillouzo,A. (1995) Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res., 55, 5574-5579.
20. Sofowora,G.G., Choo,E.F., Mayo,G., Shyr,Y. and Wilkinson,G.R. (2001) In vivo inhibition of human CYP1A2 activity by oltipraz. Cancer Chemother. Pharmacol., 47, 505-510.
21. Kim,N.D., Kwak,M.K. and Kim,S.G. (1997) Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem. Pharmacol. 53, 261-269.
22. Elegbede,J.A., Maltzman,T.H., Elson,C.E. and Gould,M.N. (1993) Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis, 14, 1221-1223.
23. Begleiter,A., Sivananthan,K., Curphey,T.J. and Bird,R.P. (2003) Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats. Cancer Epidemiol. Biomarkers Prev., 12, 566-572.
24. Kensler,T.W. (1997) Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect., 105 (suppl. 4), 965-970.
25. O'Dwyer,P.J., Szarka,C.E., Yao,K.S. et al. (1996) Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest., 98, 1210-1217.
26. Nelson,K.C., Armstrong,J.S., Moriarty,S., Cai,J., Wu,M.W., Sternberg,P.,Jr and Jones,D.P. (2002) Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent. Invest. Ophthalmol. Vis. Sci., 43, 3550-3554.
27. Haggerty,T.J., Zeller,K.I., Osthus,R.C., Wonsey,D.R. and Dang,C.V. (2003) A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc. Natl Acad. Sci. USA, 100, 5313-5318.
28. Yao,K.S. and O'Dwyer,P.J. (1995) Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 49, 275-282.
29. Kang,K.W., Cho,I.J., Lee,C.H. and Kim,S.G. (2003) Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz. J. Natl Cancer Inst., 95, 53-66.
30. Kim,D.W., Gazourian,L., Quadri,S.A., Romieu-Mourez,R., Sherr,D.H. and Sonenshein,G.E. (2000) The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene, 19, 5498-5506.
31. Martelli,A., Mattioli,F., Angiola,M., Reimann,R. and Brambilla,G. (2003) Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes. Mutat. Res., 536, 69-78.
32. Morel,F., Beaune,P.H., Ratanasavanh,D., Flinois,J.P., Yang,C.S., Guengerich,F.P. and Guillouzo,A. (1990) Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur. J. Biochem., 191, 437-444.
33. Raucy,J.L. (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab. Dispos., 31, 533-539.
34. Pichard,L., Fabre,I., Domergue,J., Joyeux,H. and Maurel,P. (1991) Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA. Transplant. Proc., 23, 2791-2793.